ClinicalTrials.gg
CompletedNCT06456333Updated Jul 3, 2024

Exploring Paraspinal Electromyographic Features in Adolescent Idiopathic Scoliosis Patients

An observational study in Scoliosis; Adolescence and Electromyography, sponsored by The First Affiliated Hospital of Zhejiang Chinese Medical University. Completed at 1 site in China. Open to participants aged 10 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-03.

Sponsored by The First Affiliated Hospital of Zhejiang Chinese Medical University · Observational

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
70
Ages
10 Years to 18 Years
Sex
All
01

Study summary

Adolescent Idiopathic Scoliosis (AIS) is a complex three-dimensional spinal deformity with onset in adolescents between the ages of 10 and 18 years, characterized by coronal curvature, sagittal imbalance and horizontal rotation of the spine. The incidence of AIS is 1-4% globally, with more females than males, and it is a common, frequent and difficult-to-treat disease that seriously jeopardizes the physical and mental health of adolescents.

Previous studies have found significant changes in the morphologic structure and physiologic characteristics of the paraspinal muscles in patients with AIS, including muscle fiber distribution, muscle contraction and relaxation capacity, the convex side of the AIS curve exhibits a higher level of electromyographic activity, and asymmetric changes in the paraspinal muscles are highly correlated with progression of scoliosis. The current single-electrode sEMG technique extracts limited muscle activity signals and is susceptible to interference from random noise. Compared with the single-electrode sEMG technique, HD-sEMG can provide rich spatiotemporal information on paraspinal muscle activity, so it is necessary to use a wide and closely spaced electrode array for signal acquisition to obtain more accurate and detailed characteristics of paraspinal muscle activity.

In summary, this study used high-density surface electromyography to collect muscle parameters of the paraspinal muscles on the concave and convex sides of AIS patients and compared them with those of healthy people to comprehensively summarize the characteristics of their paraspinal muscles, so as to provide scientific basis for the subsequent development of precise treatment plans and improvement of clinical efficacy.

Read the detailed description

Paravertebral muscle EMG signals were acquired from AIS patients and healthy controls under the BST test paradigm.

Acquisition site: paravertebral muscle at the L1-L3 level, with the electrode sheet placed 1.5 cm adjacent to the spinous process.

(Biering-Sorensen test,BST):The subject was lying prone on the bed, with the upper half of the body poking out of the bed, the anterior superior iliac spine located at the edge of the bed, both lower limbs partially immobilized on the bed with straps, both hands crossed in front of the chest grasping the contralateral shoulder and tightly pressed against the chest wall, and the torso was suspended in the air and parallel to the floor, and the patient stopped the test when he/she maintained this position for 90s.

Observation indicators:

1, the average change (mean) characteristics of each channel signal, including the 32 channels of the root mean square value (RMS), mean power frequncy(MPF), fractal dimension(FD),Slope sign change(SSC), a total of 4 types of indicators-reflecting the strength and fatigue of muscle contractions..

02

Conditions studied

  • Scoliosis; Adolescence
  • Electromyography

Browse trials for

Keywords

  • Adolescent idiopathic scoliosis
  • high-density surface electromyography
  • Cross-sectional study
03

In context

Scoliosis

603 studies on the registry are indexed under Scoliosis; 141 are open to participants now.

This study's enrollment of 70 is below the median of 84 across 236 observational studies indexed under Scoliosis.

Browse Scoliosis studies →

Lead sponsor

The First Affiliated Hospital of Zhejiang Chinese Medical University is the lead sponsor of 38 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

AIS patients and healthy control populations

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with a diagnosis of AIS
  • Any gender, age 10-18 years old
  • Signed informed consent and able to cooperate with follow-up
  • Ability to cooperate with electromyography examination and evaluation, and to perform measurements of relevant indexes.

Exclusion criteria

Exclusion Criteria:

  • Subjects with spine-related diseases such as Marfan's syndrome
  • Subjects with previous spine-related diseases such as ankylosing spondylitis, spinal neurofibroma, spinal tuberculosis, spinal trauma, etc
  • Subjects with comorbid serious medical diseases and patients with psychiatric disorders
  • Subjects with ECOG scores of >2, which may have an effect on the results of the study
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
70 participants (actual)
Patient registry
No

Groups and cohorts

  • Adolescent idiopathic scoliosis patients(Observation Group)

    Acquisition equipment:SAGA high-density electromyography system (TMSi, New Zealand).Acquisition site: paravertebral muscle at the L1-L3 level, with the electrode sheet placed 1.5 cm adjacent to the spinous process.Acquisition process: ① Place the electrode sheet and fix it. ② The subject was instructed to complete the specified movements according to the experimental paradigm and the EMG signals were recorded simultaneously.Experimental Paradigm:Biering-Sorensen test,BST:The subject was lying prone on the bed, with the upper half of the body poking out of the bed, the anterior superior iliac spine located at the edge of the bed, both lower limbs partially immobilized on the bed with straps, both hands crossed in front of the chest grasping the contralateral shoulder and tightly pressed against the chest wall, and the torso was suspended in the air and parallel to the floor, and the patient stopped the test when he/she maintained this position for 90s.

    Device: High-density surface electromyography

  • Healthy population(Control Group)

    Same intervention as the observation group.

    Device: High-density surface electromyography

Interventions

  • DeviceHigh-density surface electromyography

    Electromyographic signals were acquired from the paravertebral muscles in apical vertebral in patients with AIS using SAGA High Density Myoelectrics (TMSi International, New Zealand)

06

What researchers measure

Primary outcomes

  1. root mean square value (RMS)

    The square root of the mean value of the amplitude of the sEMG signal over a certain time window is commonly used to assess the strength of muscle contraction and fatigue.

    Time frame: Day 1

  2. mean power frequncy(MPF)

    The average of the power frequency distribution of the sEMG signals generated during a muscle contraction can be used to assess the force and fatigue of a muscle contraction.

    Time frame: Day 1

  3. fractal dimension(FD)

    The complex waveforms were categorized into multiple dimensions, and each dimension was analyzed by typing.

    Time frame: Day 1

  4. Slope sign change(SSC)

    The number of times the sign of the rate of change of amplitude changes in the waveform of the sEMG signal is commonly used to indicate an impending fluctuating change in the state of the surface EMG signal.

    Time frame: Day 1

07

Study locations

1 site
  • The First Affiliated Hospital of Zhejiang Chinese Medical University
    Hangzhou, Zhejiang 310006, China
08

References and documents

Study documents

  • Informed consent form · Jul 14, 2022

Documents are hosted by the registry — open the source record to download them.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Aug 2022 to primary completion in Dec 2023, 16 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 7, 2024
First posted
Jun 13, 2024
StartActual
Aug 1, 2022
Primary completionActual
Dec 31, 2023
CompletionActual
May 31, 2024
Last update
Jul 3, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 3, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06456333
Lead sponsor
The First Affiliated Hospital of Zhejiang Chinese Medical University
Responsible party
Sponsor
First posted
Jun 13, 2024
Start date
Aug 1, 2022
Primary completion
Dec 31, 2023
Completion
May 31, 2024
Last update
Jul 3, 2024

Study contacts

Honggen Du, doctor
study director · The First Affiliated Hospital of Zhejiang Chinese Medical University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion